Igm Biosciences Stock Filter Stocks by Fundamentals
| IGMS Stock | USD 1.27 0.01 0.78% |
Fundamental analysis of IGM Biosciences allows traders to better anticipate movements in IGM Biosciences' stock price by examining its financial health and performance throughout various phases of its business cycle.
IGM | Shares Owned by Insiders | Build AI portfolio with IGM Stock |
IGM Biosciences Current Valuation Drivers
We derive many important indicators used in calculating different scores of IGM Biosciences from analyzing IGM Biosciences' financial statements. These drivers represent accounts that assess IGM Biosciences' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of IGM Biosciences' important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 2.7B | 982.0M | 706.7M | 434.7M | 369.7M | 557.2M | |
| Enterprise Value | 2.5B | 877.4M | 626.6M | 362.7M | 388.4M | 508.7M |
IGM Biosciences Institutional Holders
Institutional Holdings refers to the ownership stake in IGM Biosciences that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of IGM Biosciences' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing IGM Biosciences' value.| Shares | Northern Trust Corp | 2025-03-31 | 187 K | Two Sigma Investments Llc | 2025-03-31 | 139.8 K | Charles Schwab Investment Management Inc | 2025-03-31 | 125.6 K | Verition Fund Managegment, Llc | 2025-03-31 | 119.1 K | Bruce & Co Inc | 2025-03-31 | 100 K | Eagle Bay Advisors Llc | 2025-06-30 | 99.6 K | Two Sigma Advisers, Llc | 2025-03-31 | 90.5 K | Acadian Asset Management Llc | 2025-03-31 | 85.8 K | Woodline Partners Lp | 2025-03-31 | 69.6 K | Baker Bros Advisors Lp | 2025-03-31 | 4.1 M | Siren, L.l.c. | 2025-03-31 | 3.3 M |
IGM Fundamentals
| Return On Equity | -2.46 | ||||
| Return On Asset | -0.37 | ||||
| Operating Margin | (62.17) % | ||||
| Current Valuation | (31.71 M) | ||||
| Shares Outstanding | 34.8 M | ||||
| Shares Owned By Insiders | 37.56 % | ||||
| Shares Owned By Institutions | 47.52 % | ||||
| Number Of Shares Shorted | 393.58 K | ||||
| Price To Earning | (7.72) X | ||||
| Price To Book | 109.51 X | ||||
| Price To Sales | 28.51 X | ||||
| Revenue | 2.68 M | ||||
| Gross Profit | (129.42 M) | ||||
| EBITDA | (199.47 M) | ||||
| Net Income | (195.79 M) | ||||
| Cash And Equivalents | 469.14 M | ||||
| Cash Per Share | 10.95 X | ||||
| Total Debt | 45.19 M | ||||
| Debt To Equity | 0.09 % | ||||
| Current Ratio | 10.79 X | ||||
| Book Value Per Share | 0.01 X | ||||
| Cash Flow From Operations | (153 M) | ||||
| Short Ratio | 3.55 X | ||||
| Earnings Per Share | (3.27) X | ||||
| Target Price | 1.69 | ||||
| Number Of Employees | 54 | ||||
| Beta | 0.51 | ||||
| Market Capitalization | 76.44 M | ||||
| Total Asset | 265.71 M | ||||
| Retained Earnings | (1.02 B) | ||||
| Working Capital | 155.98 M | ||||
| Current Asset | 1.23 M | ||||
| Current Liabilities | 3.37 M | ||||
| Net Asset | 265.71 M |
About IGM Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze IGM Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of IGM Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of IGM Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for IGM Stock Analysis
When running IGM Biosciences' price analysis, check to measure IGM Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IGM Biosciences is operating at the current time. Most of IGM Biosciences' value examination focuses on studying past and present price action to predict the probability of IGM Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IGM Biosciences' price. Additionally, you may evaluate how the addition of IGM Biosciences to your portfolios can decrease your overall portfolio volatility.